A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1997
12/31/1997	CA2259222A1 Derivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one and their use as farnesyl protein transferase inhibitors
12/31/1997	CA2259150A1 Reduction of cardiotoxicity of an antitumor agent using manganese compound
12/31/1997	CA2259008A1 Il-8 receptor antagonists
12/31/1997	CA2258956A1 Combinations comprising vx478, zidovudine, ftc and/or 3tc for use in the treatment of hiv
12/31/1997	CA2258915A1 Anticoagulant agents
12/31/1997	CA2258885A1 Tricyclic benzazepine vasopressin antagonists
12/31/1997	CA2258851A1 Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications
12/31/1997	CA2258850A1 Il-8 receptor antagonists
12/31/1997	CA2258781A1 Cosmetic compositions
12/31/1997	CA2258753A1 Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders
12/31/1997	CA2258744A1 Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications
12/31/1997	CA2258630A1 Fluoro labelled anthracyclinone and anthracycline derivatives for treatment and diagnosis of amyloidosis
12/31/1997	CA2258299A1 Chelating agents and their metal chelates for treating free radicals induced conditions
12/31/1997	CA2258199A1 Topical gel composition containing a combination of a nsaid and a xanthine derivative
12/31/1997	CA2258100A1 1,2,4-benzothiadiazine derivatives, their preparation and use
12/31/1997	CA2257964A1 Spiro-piperidine derivatives and their use as therapeutic agents
12/31/1997	CA2257404A1 Matrix metalloproteinase inhibitors
12/31/1997	CA2257063A1 Nerve process growth modulators
12/31/1997	CA2255863A1 Progestogen-anti-progestogen regimens
12/31/1997	CA2255651A1 Use of a tachykinin antagonist for the manufacture of a medicament for the treatment of emesis
12/31/1997	CA2252809A1 New synthetic catechol derivatives, method for production and use thereof
12/31/1997	CA2231732A1 Sustained release sufentanil compositions
12/30/1997	US5703247 Anticarcinogenic agents
12/30/1997	US5703243 Intermediates for pyrrolidylthiocarbapenem derivative
12/30/1997	US5703240 Analgesics; antiinflammatory agents; nervous system disorders; psychological disorders; gastrointestinal disorders
12/30/1997	US5703239 Indanylpiperidines as melatonergic agents
12/30/1997	US5703237 N-Aminoalkyl-2-anthraquinonecarboxamides; new dopamine receptor subtype specific ligands
12/30/1997	US5703236 Tetrahydrofuran antifungals
12/30/1997	US5703235 N-Aminoalkyl-2-anthracenecarboxamides; new dopamine receptor subtype specific ligands
12/30/1997	US5703231 Process for making antimicrobial compounds
12/30/1997	US5703230 Meso-monoiodo-substituted tetramacrocyclic compounds and methods for making and using the same
12/30/1997	US5703188 Process for removing bile salts from a patient and compositions therefor
12/30/1997	US5703128 Anti-osteopathic composition
12/30/1997	US5703127 Administering methionine with a sweetener
12/30/1997	US5703125 Substituted β-amino acid derivatives useful as platelet aggregation inhibitors
12/30/1997	US5703122 Ascorbic acid compositions for reducing irritation of topically applied active ingredients
12/30/1997	US5703121 Method of treating disorders of the melatoninergic system and a certain benzofuran containing compound
12/30/1997	US5703118 Use of benzopyran derivatives for the treatment of pathologies associated with the NA+ -independent CI-/HCO3 -exchanger
12/30/1997	US5703117 Hydrolysis-promoting hydrophobic taxane derivatives
12/30/1997	US5703113 Benzopyran derivatives
12/30/1997	US5703112 Method of preventing emesis using tetrahydrobenz CD!indole-6-carbonxamides
12/30/1997	US5703111 Stable injectable formulation of BMY-25067
12/30/1997	US5703109 Cyanophenyl-1,2,4-triazole derivative
12/30/1997	US5703108 Osteoporosis
12/30/1997	US5703106 Treating various cardiovascular, urogenital, brain disorders
12/30/1997	US5703104 Applying to skin of a mammal to decrease the percutaneous absorption of toxic chemicals
12/30/1997	US5703103 Thiazolylpyrazolinones and their use for protecting technical materials
12/30/1997	US5703101 Composition for treatment of dependency on cocaine or amphetamines comprising bromocriptine agonist and fluphenazine antagonist in amounts to preclude intoxication or overdosing and reduce satisfaction and withdrawal symptoms
12/30/1997	US5703100 Modulators of acetylcholine receptors
12/30/1997	US5703099 Treatment of thrombosis, arteriosclerosis, ischemic heart diseases, gastric ulcer or hypertension
12/30/1997	US5703098 Inhibitors of cytokines including tumor necrosis factor
12/30/1997	US5703097 Antiulcer agents
12/30/1997	US5703096 Oxime derivatives, their preparation and their therapeutic use
12/30/1997	US5703095 Prevention ferritin from releasing oxygen
12/30/1997	US5703094 Quinolone- and naphthyridonecarboxylic acid derivatives
12/30/1997	US5703092 Hydroxamic acid compounds as metalloprotease and TNF inhibitors
12/30/1997	US5703091 Suitable for the control of diseases
12/30/1997	US5703090 Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
12/30/1997	US5703088 Topical application of spiperone or derivatives thereof for treatment of pathological conditions associated with immune responses
12/30/1997	US5703087 Phenyl indole compounds
12/30/1997	US5703084 Adenosine deaminase inhibitors
12/30/1997	US5703083 Therapy for psychological disorders
12/30/1997	US5703082 Enantiomers of 1- (4-chlorophenyl)phenylmethyl!- (4-methylphenyl)sulfonyl!pi
12/30/1997	US5703080 Method for stabilizing duocarmycin derivatives
12/30/1997	US5703079 Tetrahydrofuran antifungals
12/30/1997	US5703078 Antibiotics
12/30/1997	US5703077 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
12/30/1997	US5703076 Retroviral protease inhibitors
12/30/1997	US5703074 Osteoporosis
12/30/1997	US5703073 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
12/30/1997	US5703070 Psychological disorders
12/30/1997	US5703069 Method for inhibiting and controlling viral growth
12/30/1997	US5703068 Penem compounds
12/30/1997	US5703067 Useful in the treatment of cancer
12/30/1997	US5703066 Treating gynecological disorders
12/30/1997	US5703065 Heteroarylamino and heteroarylsulfonamido substituted 3-benyzlaminomethyl piperidines and related compounds
12/30/1997	US5703063 Phosphocholine conjugated steroid and carrier or diluent; increased bioavailability
12/30/1997	US5703062 N-het-substituted glycerophosphoethanolamines
12/30/1997	US5703060 Uses of aloe products in the prevention and treatment of infections and infestations
12/30/1997	US5703058 Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent
12/30/1997	US5703057 Expression library immunization
12/30/1997	US5703054 Oligonucleotide modulation of protein kinase C
12/30/1997	US5703052 Sterodial glycosides for treating hypercholesterolemia
12/30/1997	US5703051 Therapeutic uses of melanin
12/30/1997	US5703050 Inhibit platelet aggregation, metastasis of carcinoma cells, osteoclast binding to bone surface
12/30/1997	US5702924 Process for preparing antiparasitic agents
12/30/1997	US5702890 Inhibitors of alternative alleles of genes as a basis for cancer therapeutic agents
12/30/1997	US5702880 Aqueous solution comprising specified concentrations of potassium, sodium, magnesium, calcium and chloride ions, hydroxyethyl starch, glucose, lactate buffer
12/30/1997	US5702752 Production of isoflavone enriched fractions from soy protein extracts
12/30/1997	US5702725 Hydromorphone therapy
12/30/1997	US5702724 Compressing inclusion compound containing diclofenac or salt and cyclodextrin into tablets
12/30/1997	US5702721 Multilayer
12/30/1997	US5702720 Involving an acrylate or mathacrylate based copolymer, a skin penetration enhancer, a polyvinylpyrrolidone polymer and flurbiprofen drug; antiinflamatory, analgesic and antipyretic agent
12/30/1997	US5702719 Substantially purified beta (1,3) finely ground yeast cell wall glucan composition with dermatological and nutritional uses
12/30/1997	US5702711 Method for enhancing the rate of skin permeation of lactic acid through use of the L-enantiomer
12/30/1997	US5702710 Treatment of hair, skin disorders
12/30/1997	US5702696 For treatment of iron overload disorders
12/30/1997	US5702694 Compositions for treating corns, calluses and warts
12/30/1997	US5702688 Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use
12/30/1997	CA2142707C Benzo-fused lactams promote release of growth hormone

1 ... 6707 6708 6709 6710 6711 6712 6713 6714 6715 6716 6717 6718 6719 6720 6721 6722 6723 6724 6725 6726 6727 ... 7860